【结 构 式】 |
【药物名称】 【化学名称】1-[2-[3-(Benzyloxycarbonyl)phenyl]acetyl]-3(S)-(4-hydroxybenzyl)-4-oxoazetidine-2(S)-carboxylic acid benzyl ester 【CA登记号】193959-27-2, 193959-22-7 (racemic, cis-isomer) 【 分 子 式 】C34H29NO7 【 分 子 量 】563.61273 |
【开发单位】Lilly (Originator) 【药理作用】ONCOLYTIC DRUGS, Prostate Cancer Therapy, Serine Protease Inhibitors |
合成路线1
The precursor acid chloride (VII) was synthesized from isophthalic acid (I) as follows: Treatment of the triethylammonium salt of (I) with benzyl bromide provided the mono-benzyl ester (II). Acid chloride (III) was then formed by reaction of (II) with oxalyl chloride in the presence of a catalytic amount of DMF. Arndt-Eistert homologation of (III) to produce (VI) was achieved via reaction with diazomethane to yield the intermediate diazo ketone (IV). Wolff rearrangement of diazo ketone (IV) in the presence of Ag2O in hot trichloroethanol furnished the trichloroethyl ester (V). Reductive cleavage of the trichloroethyl ester group of (V) with Zn and HOAc then gave the carboxylic acid (VI). This was subsequently activated as the acid chloride (VII) by using oxalyl chloride and DMF.
【1】 Adlington, R.M.; Baldwin, J.E.; Becker, G.W.; et al.; Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen. J Med Chem 2001, 44, 10, 1491. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 50926 | m-Phthalic acid; Isophthalic acid; Benzene-1,3-dicarboxylic acid; 1,3-Benzenedicarboxylic acid | 121-91-5 | C8H6O4 | 详情 | 详情 |
(II) | 50927 | 3-[(benzyloxy)carbonyl]benzoic acid | C15H12O4 | 详情 | 详情 | |
(III) | 50928 | benzyl 3-(chlorocarbonyl)benzoate | C15H11ClO3 | 详情 | 详情 | |
(IV) | 50929 | C16H14N2O3 | 详情 | 详情 | ||
(V) | 50930 | benzyl 3-[2-oxo-2-(2,2,2-trichloroethoxy)ethyl]benzoate | C18H15Cl3O4 | 详情 | 详情 | |
(VI) | 50931 | 2-[3-[(benzyloxy)carbonyl]phenyl]acetic acid | C16H14O4 | 详情 | 详情 | |
(VII) | 50932 | benzyl 3-(2-chloro-2-oxoethyl)benzoate | C16H13ClO3 | 详情 | 详情 |
合成路线2
The homochiral azetidinone (IX) was prepared from the known beta-lactam (VIII) by N-silylation with tert-butyldimethylsilyl chloride followed by catalytic hydrogenolysis of the benzyl ester. The 3-silylated azetidinone intermediate (X) was obtained by treatment of the lithium enolate of (IX) with trimethylsilyl chloride. Subsequent Peterson reaction of (X) with the 4-silyloxybenzaldehyde (XI) and LDA furnished olefin (XII) as a mixture of geometric isomers. After esterification of the carboxylate group of (XII) with benzyl alcohol in the presence of EDC to yield (XIII), the catalytic hydrogenation of the olefin double bond of (XIII) gave rise to the cis-azetidinone (XIV). The N-tert-butyldimethylsilyl group of (XIV) was selectively removed by treatment with HF in acetonitrile to afford (XV). Acylation of the lactam N of (XV) with acid chloride (VII) in the presence of sodium hexamethyldisilazide provided (XVI). The remaining silyl group of (XVI) was finally removed by treatment with ammonium hydrogen difluoride in NMP-DMF.
【1】 Adlington, R.M.; Baldwin, J.E.; Becker, G.W.; et al.; Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen. J Med Chem 2001, 44, 10, 1491. |
【2】 Chen, B.; Adlington, R.M.; Baldwin, J.E.; et al.; Design and synthesis of novel monocyclic beta-lactam inhibitors of prostate specific antigen. Bioorg Med Chem Lett 1997, 7, 13, 1689. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XIIa) | 50935 | (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(Z)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylic acid | C33H41NO4Si2 | 详情 | 详情 | |
(XIIb) | 50936 | (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(E)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylic acid | C33H41NO4Si2 | 详情 | 详情 | |
(XIIIa) | 50937 | benzyl (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(Z)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylate | C40H47NO4Si2 | 详情 | 详情 | |
(XIIIb) | 50938 | benzyl (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(E)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylate | C40H47NO4Si2 | 详情 | 详情 | |
(VII) | 50932 | benzyl 3-(2-chloro-2-oxoethyl)benzoate | C16H13ClO3 | 详情 | 详情 | |
(VIII) | 50942 | (S)-Benzyl 2-azetidinone-4-carboxylate; Benzyl (S)-4-oxo-2-azetidinecarboxylate | 72776-05-7 | C11H11NO3 | 详情 | 详情 |
(IX) | 49426 | (2S)-1-[tert-butyl(dimethyl)silyl]-4-oxo-2-azetidinecarboxylic acid | C10H19NO3Si | 详情 | 详情 | |
(X) | 50933 | lithium (2R)-1-[tert-butyl(dimethyl)silyl]-4-oxo-3-(trimethylsilyl)-2-azetidinecarboxylate | C13H26LiNO3Si2 | 详情 | 详情 | |
(XI) | 50934 | 4-[[tert-butyl(diphenyl)silyl]oxy]benzaldehyde | C23H24O2Si | 详情 | 详情 | |
(XIV) | 50939 | benzyl (2S,3S)-1-[tert-butyl(dimethyl)silyl]-3-(4-[[tert-butyl(diphenyl)silyl]oxy]benzyl)-4-oxo-2-azetidinecarboxylate | C40H49NO4Si2 | 详情 | 详情 | |
(XV) | 50940 | benzyl (2S,3S)-3-(4-[[tert-butyl(diphenyl)silyl]oxy]benzyl)-4-oxo-2-azetidinecarboxylate | C34H35NO4Si | 详情 | 详情 | |
(XVI) | 50941 | benzyl (2S,3S)-1-(2-[3-[(benzyloxy)carbonyl]phenyl]acetyl)-3-(4-[[tert-butyl(diphenyl)silyl]oxy]benzyl)-4-oxo-2-azetidinecarboxylate | C50H47NO7Si | 详情 | 详情 |